DNAAF2 Gene Primary Ciliary Dyskinesia Type 10 Genetic Test
Welcome to DNA Labs UAE, where we offer the DNAAF2 Gene Primary Ciliary Dyskinesia Type 10 Genetic Test. This test is designed to detect any genetic variations or mutations in the DNAAF2 gene that may be associated with primary ciliary dyskinesia type 10 (PCD10), a rare genetic disorder characterized by defects in the structure and function of cilia.
Test Details
The DNAAF2 gene is closely linked to PCD10, which affects the tiny hair-like structures called cilia found on the surface of cells. Cilia play a crucial role in various biological processes, including the movement of fluids and particles. By analyzing the DNA sequence of an individual’s genes using Next-Generation Sequencing (NGS) technology, we can identify any mutations or variations in the DNAAF2 gene that may be contributing to PCD10.
Components and Price
The cost of the DNAAF2 Gene Primary Ciliary Dyskinesia Type 10 Genetic Test is AED 4400.0. The test requires either a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery
After the sample is collected, the report will be delivered within 3 to 4 weeks.
Test Type and Doctor
The DNAAF2 Gene Primary Ciliary Dyskinesia Type 10 Genetic Test falls under the category of Ear Nose Throat Disorders. It is recommended to consult with an ENT doctor for this test.
Test Department
The DNAAF2 Gene Primary Ciliary Dyskinesia Type 10 Genetic Test is conducted in our Genetics department.
Pre-Test Information
Before undergoing the DNAAF2 Gene Primary Ciliary Dyskinesia Type 10 Genetic Test, it is important to provide the clinical history of the patient. This test is particularly relevant for individuals who are going for the CATSPER2 Gene Deafness and male infertility test. A genetic counseling session is recommended to draw a pedigree chart of family members affected by CATSPER2 Gene Deafness and male infertility, as well as the CATSPER2 related NGS Genetic DNA Test gene CATSPER16.
By undergoing the DNAAF2 Gene Primary Ciliary Dyskinesia Type 10 Genetic Test, healthcare professionals can confirm a diagnosis, understand the underlying cause of the disorder, and provide appropriate medical management or genetic counseling for affected individuals and their families.
| Test Name | DNAAF2 Gene Primary ciliary dyskinesia type 10 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ear Nose Throat Disorders |
| Doctor | ENT Doctor |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test gene CATSPER16 |
| Test Details | The DNAAF2 gene is associated with primary ciliary dyskinesia type 10 (PCD10), which is a rare genetic disorder characterized by defects in the structure and function of cilia. Cilia are tiny hair-like structures found on the surface of cells that play a crucial role in various biological processes, including the movement of fluids and particles. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of an individual’s genes. It can detect mutations or variations in specific genes, such as the DNAAF2 gene, that may be associated with certain genetic disorders like PCD10. By performing an NGS genetic test on the DNAAF2 gene, healthcare professionals can identify any genetic variations or mutations that may be contributing to primary ciliary dyskinesia type 10. This information can be helpful in confirming a diagnosis, understanding the underlying cause of the disorder, and providing appropriate medical management or genetic counseling for affected individuals and their families. |
